Regarding hepatoprotection, ICGA-A mitigates CCl4-induced hepatic fibrosis by inhibiting the high-mobility group box 1 (HMGB1)/TLR4/NF-κB signaling pathway (Liu et al., 2020b). This evidence concerns the gene HMGB1 and Hepatic fibrosis.